Skip to main content
Clinical Trials/NCT06163664
NCT06163664WithdrawnNot Applicable

Role of ChatGPT in Vestibular Schwannoma Management

University of Southern California0 sites30 target enrollmentStarted: January 1, 2027Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Enrollment
30
Primary Endpoint
Changes in scores of Decisional Conflict Scale after ChatGPT use

Study Overview

Brief Summary

Previous studies have demonstrated that patients frequently undergo significant decision conflict regarding major medical decisions in otolaryngology. There lack validated tools available for decision support for patients. While limited evidence has demonstrated that clinical decision support tools can alleviate decision conflict for patients with diagnosis in otolaryngology, conversational language models were not employed in these studies and may provide additional benefit in this context. This study seeks to evaluate the efficacy of using ChatGPT, a conversational language model with basic clinical knowledge, in alleviating decision conflict for patients with new diagnosis in otolaryngology. For this pilot study, vestibular schwannoma, a benign tumor that develops on the vestibular nerve with known clinical equipoise, has been chosen for the initial study diagnosis. Efficacy will be evaluated by comparison of responses to the Decisional Conflict Scale (DCS) and Satisfaction with Decision (SWD) scores between a group given training in ChatGPT and a control group (no ChatGPT training).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 18 years or older
  • Diagnosed with vestibular schwannoma
  • Have access to internet-enabled device that is compatible with ChatGPT

Exclusion Criteria

  • < 18 years old
  • patient without diagnosis of vestibular schwannoma
  • patient does not have access to internet-enabled device
  • patient who declines study participation

Outcomes

Primary Outcomes

Changes in scores of Decisional Conflict Scale after ChatGPT use

Time Frame: baseline, 1 week follow up, 2 week follow up

The Decisional Conflict Scale (DCS) measures 5 dimensions of decision making (feeling: uncertain, uninformed, unclear about values, unsupported; ineffective decision making). 15-item validated questionnaire. Score range 5-75 (higher score corresponding to higher levels of conflict in decision making)

Changes in scores of Satisfaction with Decision after ChatGPT use

Time Frame: baseline, 1 week follow up, 2 week follow up

The Satisfaction with Decision (SWD) scale measures satisfaction with health care decisions. 6-item validated questionnaire. Score range 5-30 (higher score corresponding to higher levels of satisfaction with decision)

Changes in scores for Knowledge on vestibular schwannoma management after ChatGPT use

Time Frame: baseline, 1 week follow up, 2 week follow up

4-item questionnaire (Likert scale) assessing participants' confidence in understanding the diagnosis and treatment options for vestibular schwannoma. Score range 5-20 (higher score corresponding to higher levels of confidence in understanding diagnosis and management of vestibular schwannoma)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Janet Choi

Assistant Professor

University of Southern California

Similar Trials